Premier Biomedical, Inc. engages in the development of graphene enhanced formulations for commercial and military applications. The company is headquartered in El Centro, California. The company went IPO on 2012-02-23. The Company’s graphene and novel additive formulations are integrated into the production process of other products. The firm is engaged in supplying large-scale industrial quantities. Its graphene blends and formulations target specific product enhancements sought by manufacturers. Its hemp-based graphene can be used in aerospace technology. The firm is developing armor using hemp graphene, which combines lightweight properties with high strength and durability, crucial for military applications.
P/E (price / listing EPS) Forward revenue growth (NTM)